Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure.
Lipids, especially essential fatty acids (EFAs), play critical roles in guiding proper fetal development. Exposure to xenobiotics that may alter the fetal supply of EFAs/lipids could potentially lead to fetotoxicity. In this study, we investigated the effects of the peroxisome proliferator chemical, di-(2-ethylhexyl)-phthalate (DEHP), on the lipid metabolomic profile of the rat fetal brain upon maternal exposure during gestation. Female Sprague-Dawley rats were orally gavaged with a control vehicle or DEHP (1,500 mg/kg) from gestational day (GD) 0 to GD 19 and fetal brain tissue was isolated at GD 20. The concentrations of 11 lipid classes [free fatty acid, free cholesterol (FC), cholesterol ester (CE), diacylglycerol (DAG), triacylglyceride, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine (PS), lysophosphatidylcholine (LYPC), cardiolipin, and sphingomyelin (SM)] were determined, as well as the differences in the composition of individual fatty acids. The total lipid concentration decreased with DEHP exposure, particularly for FC and SM, by 33 and 54%, respectively. The same trend was observed in the fatty acid compositions, particularly the unsaturated fatty acids, where a greater decrease was observed with longer fatty acid chain length. The compositions of docosahexaenoic acid decreased significantly in five lipid classes (P < 0.05), including CE (43%), DAG (60%), PS (33%), LYPC (35%), and SM (40%). In contrast, the most remarkable reduction of arachidonic acid presented in two lipid classes, CE and LYPC, with a decrease of up to 33%. These results suggest that in utero exposure to DEHP alters the lipid metabolome in the fetal brain, which may lead to aberrant neurodevelopment.
Xu
Yan
Y
Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
Agrawal
Shruti
S
Cook
Thomas J
TJ
Knipp
Gregory T
GT
D000704:Analysis of Variance; D000818:Animals; D016718:Arachidonic Acid / Q000032:analysis; D001921:Brain / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002788:Cholesterol Esters / Q000032:analysis; D004051:Diethylhexyl Phthalate / Q000633:toxicity*; D004281:Docosahexaenoic Acids / Q000032:analysis; D004785:Environmental Pollutants / Q000737:chemistry / Q000633:toxicity; D005229:Fatty Acids, Monounsaturated / Q000032:analysis; D015525:Fatty Acids, Omega-3 / Q000032:analysis; D005231:Fatty Acids, Unsaturated / Q000032:analysis; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D050356:Lipid Metabolism / Q000187:drug effects; D008055:Lipids / Q000032:analysis* / Q000737:chemistry; D008244:Lysophosphatidylcholines / Q000032:analysis; D008297:Male; D018811:Maternal Exposure; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000032:analysis
D002788:Cholesterol Esters; D004785:Environmental Pollutants; D005229:Fatty Acids, Monounsaturated; D015525:Fatty Acids, Omega-3; D005231:Fatty Acids, Unsaturated; D008055:Lipids; D008244:Lysophosphatidylcholines; D014280:Triglycerides; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid; D004051:Diethylhexyl Phthalate